Key findings
- 543 and 254non-pregnant, non-lactating women aged 19 to 49 tested: Group 1 used market iodised salt, Group 2 salt supplied by the study
- 137.0 vs 130.5median urinary iodine excretion (µg/L), Group 1 versus Group 2; the difference was not significant
- 34.1% and 35.8%of women in Groups 1 and 2 had urinary iodine below 100 µg/L, classed as deficient by WHO criteria
- 6.1% and 3.1%had urinary iodine of 300 µg/L or more (excessive); differences between the groups were not significant (P = 0.380)
Abstract
- Background information
- India achieved near universal iodisation of salt for human consumption a decade ago. Recent studies in the country, indicate that despite adequate intake of iodised salt and optimal median urinary iodine excretion (UIE), subclinical or overt hypothyroidism was seen in 10% of school children. There is a need to assess the magnitude of the iodine deficiency as assessed by UIE in women of reproductive age (WRA), pregnant and lactating women.
- Methods
- Urinary iodine excretion was estimated in two groups of non-pregnant, non-lactating WRA from low middle-income group living in three well defined blocks in Southwest Delhi. Group 1 had been using powdered packaged iodised salt purchased in the market for 1-10 years. Group 2 received adequately iodised salt from our institution and had used it continuously for 6-12 months.
- Results
- In Group 1 median urinary iodine excretion was 137.0 µg/L (inter-quartile range was 80.0-202.0 µg/L); in Group 2 median UIE was 130.5 µg/L (inter-quartile range was 80-193.8 µg/L). There were no significant differences in the median UIE between Group 1 and Group 2. Iodine nutritional status of women in Group 1 and 2 were assessed according to the WHO criteria. In both the groups about 1/3rd of the women had urinary iodine levels below 100 µg/L; about 5% of the women in both the groups had urinary iodine level ≥ 300 µg/L. None of the differences in iodine nutritional status as assessed by UIE between the two groups were statistically significant.
- Conclusion
- The median UIE and the iodine nutritional status in WRA reported in the present study is similar to the data on median UIE reported in national surveys in Indian school children. Further studies are needed to assess the magnitude of iodine deficiency in WRA, pregnant and lactating women.
Introduction
Globally iodine deficiency is the single most important preventable cause of brain damage; iodine deficiency is associated with a wide spectrum of disorders ranging from cretinism, lower cognitive ability, reduced reproductive capacity, low work productivity1. Universal consumption of iodised salt is the safe, simple, inexpensive and effective method of preventing iodine deficiency disorders2. In India, the Kangra Valley study demonstrated that use of iodised salt resulted in reduction in goitre prevalence3. In 1962, India became the first developing country to initiate the goitre control programme; the programme supplied iodised salt to the sub-Himalayan terai region with high prevalence of goitre4. Subsequent surveys showed that there are pockets of iodine deficiency in all states. In 1992 the programme adapted Universal Salt Iodisation (USI) strategy for the entire country and was renamed as National Iodine Deficiency Disorders Control Programme (NIDDCP). The progress of NIDDCP is monitored by assessing the iodised salt production, distribution, % household using iodised salt. The impact of the use of the iodised salt is monitored by assessing total goitre rate, and median urinary iodine excretion (UIE) in spot sample of urine in school children2. In India data from national surveys conducted in the last decade indicate that over 90% of the households have been consuming iodised salt5–8. There has been substantial reduction in the goitre rates and improvement in median UIE8,9.
In the last century iodised salt was packed, transported, stored in jute bags and iodine loss due to leaching was high. To ensure that despite high leaching losses, iodine content of salt at the household level remained at 15 ppm, Prevention of Food Adulteration and later Food Safety and Standards Authority of India (FSSAI) mandated that iodine content should be at least 30 ppm at the manufacturing level; no upper limit for iodine fortification was set. Currently iodised salt is packed in plastic packs and iodine loss due to leaching is minimal10. UIE surveys conducted two decades earlier had shown that median UIE level was ≥100 μg/L in over 80% of the districts, suggesting that the iodisation levels were adequate. However, UIE was over 200 μg/L in 10% of the districts; occasionally, median UIE levels above 300 μg/L were reported11. The UIE levels above 300 μg/L might be due to the higher iodine content of salt at manufacturers’ level. In 2021 FSSAI issued a notification that iodine content of iodised salt at the manufacturer level should be between 20 and 30 ppm12. Research studies and national surveys undertaken subsequent to the notification showed that there was a reduction in both median UIE and in the proportion of children with high UIE8,9,13. In United States during the 1980s UIE was high due to excessive intake of iodine in processed foods and dairy products; the resultant higher prevalence of hypothyroidism and hyperthyroidism was a public health concern14. Over decades adjustments in the dairy and bread industries had helped to stabilize iodine intake within the optimal range for the general population14. Ample global and Indian studies and surveys document that in the post universal iodisation of salt era, there had been a decline in IDD, but both iodine deficiency and iodine excess continues to exist1,8,9,14. It is therefore essential that both UIE and thyroid function are monitored by all countries.
Most of the available global and Indian data on IDD monitoring is based on goitre prevalence and UIE on spot urine collection in school-age children recommended by WHO2. Women from reproductive age (WRA) are a vulnerable group for iodine deficiency. Iodine requirements increase during pregnancy and lactation to meet the needs of the foetus and growing breast-fed infant. Data on urinary iodine excretion in women of childbearing age from nine National Health and Nutrition Examination Survey (NHANES) survey cycles (2001-2020) showed that over two decades there was a significant decline in median UIE among all women of childbearing age. Sub-group analyses revealed that pregnant and lactating women consistently exhibited median UIE below the WHO adequacy thresholds14. Iodine deficiency during pregnancy had been shown to have a devastating impact on the growth and development of the foetus15,16. Clearly there is need to monitor iodine status of WRA, pregnant and lactating women and assess the magnitude of iodine deficiency as assessed by UIE levels in them. The present study was taken up to assess UIE in WRA from urban low middle-income families in New Delhi, who had been using powdered packaged iodised salt for periods ranging from 6 months to a decade or longer.
Material and methods
The study was conducted in three purposively chosen blocks in South West Delhi, India; our institution had been undertaking studies on maternal and child nutrition in these blocks and have good rapport with the families and frontline health and nutrition service providers. A household census of the area was conducted and low middle-income families living in the area and had been using packaged iodised salt for one year or longer were identified. Participant Information sheet informing the family about the study was given and study details were discussed with family members available at home during visits. The research team emphasised the importance of having one identified woman in the family who usually cooks and serves the family meals, to provide information about the salt used for cooking and willing to provide a spot sample of urine for estimating urinary iodine excretion. One week later the families were revisited; informed consent was obtained from women who were willing to participate in the study and provide urine samples.
The study aimed at comparing urinary iodine excretion in two groups of women:
Group 1 Spot urine sample was collected in 543 women who had been using powdered, packaged iodised salt purchased in the market for cooking food for periods ranging from 1 year to a decade or longer;
Group 2 Our institution procured iodised salt from a producer who certified that each consignment of salt that we purchased had iodine level between 20 and 30 ppm at manufacturer level. Our institution supplied the salt every month to families who had consented to participate in the study, use only the iodised salt that we provided for cooking. During the monthly visits the research teams ascertained from women in these families:
- confirmation that the family had used only the salt provided by us for cooking meals,
- amount of salt consumed in the previous month,
- amount of salt required for the next month.
Socio-demographic details of the families in both the Groups were obtained at enrolment. Height (measured using wall-mounted stature-meter; accuracy of 0.1cm) weight (measured using digital weighing machine accuracy of 100g) and blood pressure (using a digital blood pressure monitor) were measured in the women enrolled for the study. Spot urine sample was collected from WRA from Gr 1 and Gr 2 families; samples were stored at -20°C in deep freezer till analysis. Coded samples were sent to the lab for analysis. Estimation of UIE was done using the Microplate method based on Sandell-Kolthoff Reaction. Urine sample was digested with ammonium persulfate to eliminate interfering substances and to release iodide. Iodide catalyzes the reduction of the yellow-colored ceric (IV) ions by arsenic to colorless ceric (III) ions and elemental iodine, allowing the spectrophotometric detection of the color disappearance. An in-house pooled sample was prepared and iodine estimation was carried out 20 times and the mean and standard deviation was established. The pooled sample was run with each batch of samples as a quality control measure. The laboratory also participates in external quality assurance programme ‘EQUIP’ by CDC, USA. The study was approved by the Institutional Ethics Committee of Nutrition Foundation of India.
Sample size
The study aimed at comparing urinary iodine excretion (UIE, µg/L) among WRA using packaged iodised salt purchased from the market, with WRA using iodised salt produced by single manufacturer containing 15-30 ppm iodine at manufacturer level. The study was designed as an equivalence study, and the sample size was estimated using the two one-sided tests procedure for equivalence of two independent means. Previous community-based studies in the same population showed median UIE values ranging from 125 to 140 µg/L, with an interquartile range of 80-200 µg/L, corresponding to an estimated standard deviation of approximately 90 µg/L. An equivalence margin of ±20 µg/L was considered acceptable. Assuming a true difference in mean UIE between the two groups of 0 µg/L, a common standard deviation of 90 µg/L, a two-sided significance level of 0.05 and 80% power, the required sample size was 319 women per group.
Result
Urinary iodine excretion was estimated in 543 women belonging to Group 1 and 254 women belonging to Group 2. Majority of women were from nuclear families. Nearly three-fourths of the men and over half of the women had secondary school education. The majority of the men were semi-skilled or skilled workers; 1/5th worked in white-collar jobs. The majority of women were home-makers. Over 80% of households lived in one or two room tenements in brick-and-mortar buildings. The families stated that they belonged to low middle income group. Their monthly income was sufficient to ensure food security and take care of their essential requirements for education of children and health care. Because of urban housing constraints, they lived in unhygienic environment in small tenement flats. There were no differences in the socio-demographic profile between women belonging to Group 1 and Group 2. All the women enrolled for the study were between 19 and 49 years of age; none of them were pregnant or lactating.
In Group 1 the median UIE was 137.0 µg/L; in Group 2 median UIE was 130.5 µg/L (Table 1). There were statistically no significant differences in the median UIE between Group 1 and Group 2.
Table 1. Urinary iodine excretion (µg/L) in women
| Gr 1 | Gr 2 | |
|---|---|---|
| Number of women | 543 | 254 |
| Median UIE (µg/L) | 137.0 | 130.5 |
| Interquartile range (IQR) | 80.0-202.0 µg/L | 80-193.8 |
Mann Whitney U test differences between Gr 1 and gr 2 are not significant
The WHO has recommended classification of iodine status of women on the basis of median urinary iodine excretion17. Data on iodine nutritional status of women in Group 1 and 2 is given in Table 2. In both the groups about 1/3rd of the women had urinary iodine levels below 100 µg/L; about 5% of the women in both the groups had urinary iodine level ≥ 300 µg/L. None of the differences in iodine nutritional status as assessed by urinary iodine excretion between the two groups were statistically significant (Table 2).
Table 2. Comparison of UIE frequency distribution between Gr 1 and Gr 2
| Urinary iodine (µg/L) | WHO Classification | Group 1 | Group 2 | ||
|---|---|---|---|---|---|
| Number | % | Number | % | ||
| <100 | Deficient | 185 | 34.1 | 91 | 35.8 |
| 100–199 | Adequate | 218 | 40.1 | 104 | 40.9 |
| 200–299 | More than adequate | 107 | 19.7 | 51 | 20.1 |
| ≥300 | Excessive | 33 | 6.1 | 8 | 3.1 |
| Total | 543 | 100.0 | 254 | 100.0 | |
Pearson chi-square test: P = 0.380 not significant
Discussion
Globally goitre and iodine deficiency disorders (IDD) had been recognised as major public health problems. Universal salt iodisation (USI) is the primary strategy for the prevention and control of IDD. Global review of the IDD control programmes in late 1980s showed that the progress in many countries was slow. Realising the urgent need to accelerate the progress in IDD control programme, the World Health Assembly in 1991, adopted the goal of eliminating iodine deficiency as a public health problem.
India was one of the first developing countries in the world to initiate a salt iodisation programme4. The National Goitre control programme supplied iodised to salt to the sub-Himalayan region with high prevalence of goitre. Surveys carried out in the 1980s showed that all states in the country had pockets of iodine deficiency disorders. In view of this, a policy decision was taken to iodize all edible salt. By 1990, the country was producing adequate iodised salt to meet to meet the requirements of Indian population. In 1992 the National Iodine Deficiency Disorders Control Programme (NIDDCP) was initiated with the objective of ensuring 100% household consumption of adequately iodized salt and reducing IDD prevalence to below 5%10.
In India, National surveys provide data on % of household consuming iodised salt. Data from NHFS 2 (1998-99) showed despite adequate production and distribution of iodised salt, proportion of families consuming iodised salt was quite low. Concerned about the tardy progress of the IDD control programme, a policy decision was taken to ban the sale of non-iodised salt for human consumption10. Within a decade of making iodised salt mandatory for human consumption, % of families consuming iodised salt increased from 51% (NFHS3, 2005-06) to 93.1% (NFHS 4, 2015-16); NFHS 5 (2019-21) and NFHS 6 (2023-24) reported that household consumption of iodised salt has been sustained at this level over the next decade5–7. Other national surveys and research studies have also confirmed that ban on sale of non-iodised salt for human consumption increased percentage of families consuming of iodised salt to over 90%. The National Iodine and Salt Intake Survey (NISI) 2014-2015 reported that at national level coverage of iodised salt was 91·7 %; adequately iodised salt (≥15 ppm) was consumed by 77·5% families8. There are substantial inter-state differences in use of iodised salt; North and North-East zones in the erstwhile goitre belt were on the verge of achieving universal salt iodisation while southern zone who had very little experience of health consequences of IDD lagged behind8.
Monitoring the National Iodine Deficiency Disorders Control Programme
Under the National iodine deficiency disorder control programme (NIDDCP) different organisations were given the responsibility of monitoring different aspects of the programme. The Office of the salt commissioner, Jaipur has the responsibility to regulate manufacture, supply and distribution of salt in the country and quality control of salt at manufacturer level. State Health Directorates monitor distribution and quality control of iodised salt at retail level10. Household consumption of iodised salt is being assessed as a part of the national surveys.
Goitre prevalence and UIE from spot urine samples collected in school children (6-12 years of age) are used globally and in India to assess iodine nutritional status of the population. India has established a National Reference Laboratory at National Centre for Disease Control (NCDC), Delhi; four regional laboratories and a network of State level IDD control cells and IDD monitoring labs have been established10. NIDDCP envisages a district-level IDD survey once in every five years for monitoring implementation and impact of NIDDCP.
Surveys conducted two decades ago in 116 districts in India, showed that median UIE levels were above 100 μg/L in over 80% of the districts, suggesting that the iodisation levels were adequate. However, UIE was over 200 μg/L in 10% of the districts; occasionally, median UIE levels above 300 μg/L were reported. Delhi was one of the states in which high median UIE had been reported11. While UIE below 100 µg/L is associated with increased risk of iodine deficiency disorders, high UIE is associated with increased risk of hyperthyroidism and autoimmune thyroiditis. Therefore, iodisation at manufacturing should be kept at a level which will ensure that that median UIE in general population is between 100-200 µg/L.
In the last century iodine loss during transport, storage and retail sale was high in India because iodised salt was packed in jute bags, sent in open rail wagons and salt bags were kept open in shops. In order to ensure that adequate iodine reached the consumer, the notification by the regulatory authorities kept minimum iodine content of salt at 30 ppm and did not notify upper limit of iodine10. The reported higher UIE levels in some districts might be due to the fact that manufacturer were supplying these districts with iodised salt with higher iodine because upper limit of iodine content in salt had not been specified in the earlier notification. Some firms were using older machines for mixing the salt with iodate; errors in mixing could have resulted in higher iodine content in the salt. Over years loss of iodine between manufacturer and consumer use was minimised because iodised salt is now packed in 1 kg consumer poly packs; there had been efforts to upgrade the machines used for mixing the salt with iodine. Taking these into account FSSAI issued a notification that iodine content at the manufacturing level should be between 20 and 30 ppm12. Research studies, national surveys and multicentre research studies in school children undertaken after the FSSAI notification, indicate that the median UIE is now within the expected range9,10,13. The rapidity with which the revised notification has been implemented by the firms could be partly due to the intensive efforts made to inform the manufacturers about the rationale for change of the iodine content on the salt and informing them that by following the notification, the firms will be able to reduce the cost of the iodine fortification of salt. Perhaps, the manufacturers who were living through the ongoing nutrition transition where they were facing dual nutrition (concurrent under- and over-nutrition) and disease burden (communicable and non-communicable diseases), realised the importance of ensuring that iodine content at the manufacturing level is kept at the optimal range between 20 and 30 ppm so that adverse health consequences of both low and high iodine intake can be prevented.
The objective of the IDD control programme is to prevent adverse impact of iodine deficiency on health. Available global and Indian data indicate that universal iodisation of salt programme has reduced prevalence but not eliminated IDD. Four decades after launch of USI program in India a national multi-centre cross sectional study was undertaken in children between the ages of 10-18 years from six regions across India9 to assess the process and impact of universal salt iodisation. Data from the study showed that the:
- median iodine content in salt samples was 27.5 ppm (IQR: 23.26-31.72),
- the median UIE value was 140.8 ug/L (IQR: 87.12-208.24),
- 10% of children had grade 1 goitre,
- Sub-clinical hypothyroidism and overt hypothyroidism were detected in 12.4% & 0.9% of children.
These data indicate that universal salt iodisation programme has to be assessed not only by iodine intake and UIE parameters but also thyroid function tests. The findings that despite adequate intake of iodised salt and optimal median UIE children, subclinical and overt hypothyroidism is seen in 10% of the children clearly indicate the need to continue undertaking the IDD surveys once every five years.
Monitoring UIE in women of reproductive age
Most of the available global and Indian data on monitoring of the universal salt iodisation programmes were based on spot urine collection in school-age children as recommended by WHO2. Children and adolescents are a vulnerable group for IDD; it was convenient to combine UIE survey with goitre surveys in school children. The WRA are a vulnerable group for iodine deficiency; but very few countries are monitoring iodine nutritional status and thyroid function in WRA. This might be partly because it was felt that the ongoing school children-based monitoring provided adequate data on the process and impact of the ongoing IDD control programme.
The present study was undertaken five years after the FSSAI notification regarding iodine content of iodised salt with the objective of obtaining information on the UIE in WRA. Two groups of non-pregnant, non-lactating WRA from low middle income group families living in three well defined blocks in Southwest Delhi participated in the study:
Group 1 Prior to initiation of the present study, families in these blocks had been purchasing powdered, poly packed iodised salt from the market. Spot urine sample was collected in 543 women who had been using powdered, packaged iodised salt purchased in the market for cooking food for periods ranging from 1 year to 10 years or longer.
Group 2 Our institution procured iodised salt from a producer who certified that each consignment of salt that we purchased had iodine level between 20 and 30 ppm at manufacturer level; we provided the salt every month to the families. The families used only the iodised salt that we provided for cooking; WRA provided spot urine sample after 6-12 months use of the salt.
In Group 1 the median urinary iodine excretion was 137.0 µg/L; in Group 2 median UIE was 130.5 µg/L (Table 1). The differences in the median UIE between Group 1 and Group 2 were not statistically or functionally significant. Iodine nutritional status of women in Group 1 and 2 were assessed in both groups according to the WHO criteria. In both the groups about 1/3rd of the women had urinary iodine levels below 100 µg/L; less than 5% of the women in both the groups had urinary iodine level ≥ 300 µg/L (Table 2). None of the differences in iodine nutritional status as assessed by urinary iodine excretion between the two groups were statistically or functionally significant.
The median UIE and the iodine nutritional status in WRA reported in the present study is similar to the data on median UIA reported in the school children surveyed during the first National Iodine and Salt Intake Survey8 and the multi-centre study on iodine and thyroid status9. These data indicate that as a group, school children and WRA who have similar iodine requirements and are consuming adequately iodised salt, have similar median UIE and iodine nutritional status. Analysis of data on UIE in WRA, pregnant and lactating women from the nine rounds of NHANES USA carried out between 2000 and 2020 showed that there was a decline in median UIE in WRA and rise in the proportion of pregnant women having UIE below 100 µg/L14. Global and Indian publications indicate that over years there had been substantial reduction in iodine deficiency and their adverse health consequences in women and children; but even in the post universal iodisation era, iodine deficiency and associated health consequence continue to exist18–20.
Monitoring UIE in pregnant women
Children and WRA with mild iodine deficiency (<100 µg/L) do not face any immediate adverse health consequences. However, when the WRA conceives, she and her foetus may face the risk of potentially severe adverse consequences of iodine deficiency15,16. Iodine requirements increase during pregnancy because the mother has to meet her own iodine needs and the needs of the foetus in utero. The RDA for iodine in WRA is 150 µg /day, for pregnant women RDA is 220 µg/L21. The UIE varies with the iodine intake. The technical consultation on prevention and control of iodine deficiency in pregnant women22 recommended that the UIE cut-off of <150 µg/L may be used for assessing iodine deficiency.
Our institution had conducted diet surveys using 24 hour dietary recall method in women from food secure urban low middle income families. Energy intake in pregnant women was higher by about 100-150 Kcal mostly during the second trimester of pregnancy; salt intake in pregnant women was not higher as compared to WRA. Adverse consequences of iodine deficiency during pregnancy on the foetus are devastating; in fact, they had been the driving force behind the IDD control programmes in many countries. There are anecdotal reports that median UIE was lower and iodine deficiency (UIE <100 µg/L) was higher in pregnant women. Data from the NHANES survey suggested that iodine deficiency in pregnant women was higher but the sample size was small14. There are very few large-scale studies and surveys reporting on UIE using the current cut-off levels to define iodine nutritional status in pregnant women. The lack of data about UIE in WRA might also be attributable to fact that:
- UIE estimation and thyroid function tests in WRA and pregnant women will only provide the prevalence of iodine deficiency and hypothyroidism in these groups,
- UIE levels are not diagnostic of iodine deficiency in individual pregnant woman, and
- UIE levels will not help the clinician to identify the woman who requires iodine supplementation.
It is imperative to obtain data on iodine nutritional status in pregnant women in countries who have achieved universal iodisation of salt. As a first step the data on magnitude of iodine deficiency in pregnant women can be generated rapidly and inexpensively by undertaking UIE estimation in selected antenatal clinics.
The technical consultation on prevention and control of iodine deficiency in pregnant women concluded that in countries which have achieved universal iodisation of salt and the population is iodine sufficient, pregnant women do not need iodine supplements22. But reports of rising iodine deficiency in pregnant women as assessed by UIE levels led to advocacy for iodine supplementation during pregnancy23. The major problem is that currently there are no diagnostic tests for identifying iodine deficient pregnant women who would benefit from iodine supplementation. Almost all available studies have provided iodine supplementation to all pregnant women without any prior screening for iodine nutritional status or thyroid function. These studies reported conflicting trends regarding impact of iodine supplementation on the mother-child dyad. Two recent reviews concluded that data was insufficient for drawing conclusions on the benefits and risks of routine iodine supplementation in women before, during or after pregnancy24,25.
It is possible that research studies may come up with a diagnostic test for identifying iodine deficient pregnant women in the near future. Even when such a diagnostic test is available, it may not be possible for countries like India to screen 25-30 million pregnant women every year for detection of a small number of iodine deficient pregnant women who may benefit from iodine supplementation. Given this scenario priority should be accorded to:
- documenting the magnitude of iodine deficiency in pregnancy (as assessed by UIE <150 µg/L),
- documenting the impact if any of mild iodine deficiency in pregnant women on the foetus, and
- developing diagnostic tests to detect iodine deficiency in pregnant women.
Once these are available, it will be possible assess the need, feasibility and impact of iodine supplementation to pregnant women.
Conclusion
India had achieved near universal iodisation of salt a decade ago. Recent studies in India, indicate that despite adequate intake of iodised salt and optimal median urinary iodine excretion (UIE), subclinical or overt hypothyroidism was seen in 10% of school children. There is need to undertake surveys on iodine nutritional status and thyroid status not only in school children but also in other vulnerable groups such as WRA, pregnant and lactating women.
The present study undertook UIE estimation in two groups of non-pregnant, non-lactating WRA from urban low middle income group. Group 1 had been using powdered packaged iodised salt purchased in the market for 1-10 years. Group 2 received adequately iodised salt from our institution and had used it for 6 - 12 months. In Group 1 the median urinary iodine excretion was 137.0 µg/L; in Group 2 median UIE was 130.5 µg/L. In both the groups about 1/3rd of the women had urinary iodine levels below 100 µg/L; about 5% of the women in both the groups had urinary iodine level ≥300 µg/L There were no statistically significant differences in the median UIE or iodine nutritional status assessed by UIE between Group 1 and Group 2.
The median UIE and the iodine nutritional status in WRA reported in the present study is similar to the data on median UIE reported in national surveys in Indian school children. Further studies are needed to obtain data on magnitude of iodine deficiency in WRA, pregnant and lactating women.
Declarations
- Conflicts of interest
- The author have no conflicts of interest to declare.
- Funding
- The study was funded by a grant from Sir Dorabjee TATA Trust (Grant ID 2025-707296) and by Nutrition Foundation of India.
- Acknowledgements
- The authors acknowledge with thanks funding provided by Sir Dorabjee TATA Trust and Nutrition Foundation of India which enabled them to carry out this study. The authors thank the research staff for their meticulous work and women in the study families for their support in carrying out this study.
References
- Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012;142(4):744-750. doi:10.3945/jn.111.149393.
- World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: A guide for programme managers. 3rd ed. World Health Organization; 2007. ISBN 9789241595827. Accessed September 8, 2026. WHO publication page
- Sooch SS, Ramalingaswami V. Preliminary report of an experiment in the Kangra valley for the prevention of Himalayan endemic goitre with iodized salt. Bull World Health Organ. 1963;32(3):299-315.
- Sooch SS, Deo MG, Karmarkar MG, Kochupillai N, Ramachandran K, Ramalingaswami V. Prevention of endemic goitre with iodized salt. Bull World Health Organ. 1973;49(3):307-312.
- International Institute for Population Sciences. National Family Health Survey-4 (NFHS-4), 2015-16: India Fact Sheet. Ministry of Health and Family Welfare, Government of India; 2017. Accessed September 8, 2026. NFHS-4 India Fact Sheet
- International Institute for Population Sciences. National Family Health Survey-5 (NFHS-5), 2019-21: India Fact Sheet. Ministry of Health and Family Welfare, Government of India; 2021. Accessed September 8, 2026. NFHS-5 India Fact Sheet
- International Institute for Population Sciences. National Family Health Survey-6 (NFHS-6), 2023-24: India and State/Union Territory Fact Sheets. Ministry of Health and Family Welfare, Government of India; 2026. Accessed September 8, 2026. NFHS-6 official website
- Pandav CS, Yadav K, Salve HR, Kumar R, Goel AD, Chakrabarty A. High national and sub-national coverage of iodised salt in India: evidence from the first National Iodine and Salt Intake Survey (NISI) 2014-2015. Public Health Nutr. 2018;21(16):3027-3036. doi:10.1017/S1368980018000461.
- Marwaha RK, Dutta P, Arjunan A, Behera K, Godbole M, Jayant S, Masoodi S, Muthukrishnan J, Naik D, Sahoo J. Benefits and concerns of universal salt iodisation (USI) in Indian children four decades following iodisation program in India. Curr Dev Nutr. 2025; doi:10.1016/j.cdnut.2025.106194.
- Pandav CS, Yadav K. Journey of iodine deficiency disorders in India: Lessons learnt and the way forward. NFI Bull. 2018;39:1-7.
- Kapil U, Singh P. Current status of urinary iodine excretion levels in 116 districts of India. J Trop Pediatr. 2004;50(4):245-247. doi:10.1093/tropej/50.4.245.
- Food Safety and Standards Authority of India. Food Safety and Standards (Fortification of Foods) First Amendment Regulations, 2021. Gazette of India; September 2, 2021. Accessed September 8, 2026. FSSAI official notification
- Kumari H, Prabhakar K, Abraham RA, Lakshmy R, Kalaivani K, Ramachandran P. Urinary iodine excretion: A valuable tool for monitoring salt iodisation programme. Natl Med J India. 2025;38(5):275-280. doi:10.25259/NMJI_366_2023.
- Cheng L, Li Y, Chen Y, Wang W, Sun L, Zhang Q. Some subgroups of U.S. childbearing women are still at risk of iodine deficiency in the 21st century: a cross-sectional analysis of NHANES 2001-2020. BMC Pregnancy Childbirth. (2025)doi:10.1186/s12884-025-08554-4.
- WHO ,UNICEF: Reaching optimal iodine nutrition in Pregnant and Lactating Women and Young Children Joint Statement by the WHO and UNICEF (2007)
- Zimmermann MB. The effects of iodine deficiency in pregnancy and infancy. Paediatr Perinat Epidemiol. 2012;26(suppl 1):108-117. doi:10.1111/j.1365-3016.2012.01275.x.
- Krämer M, Kupka R, Subramanian SV, Vollmer S. Association between household unavailability of iodized salt and child growth: evidence from 89 demographic and health surveys. Am J Clin Nutr. 2016;104(4):1093-1100. doi:10.3945/ajcn.115.124719.
- Kumar S, Berkman LF. Association of inadequately iodized salt use with underweight among young children in India. Asia Pac J Public Health. 2015;27(2):185-194. doi:10.1177/1010539513477683.
- Hynes KL, Otahal P, Hay I, Burgess JR. Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the gestational iodine cohort. J Clin Endocrinol Metab. 2013;98(5):1954-1962. doi:10.1210/jc.2012-4249.
- Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet. 2013;382(9889):331-337. doi:10.1016/S0140-6736(13)60436-5.
- Food and Agriculture Organization of the United Nations, World Health Organization. Vitamin and Mineral Requirements in Human Nutrition. 2nd ed. World Health Organization; 2004. ISBN 9241546123. Accessed September 8, 2026.
- WHO Secretariat, Andersson M, de Benoist B, Delange F, Zupan J. Prevention and control of iodine deficiency sin pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr. 2007;10(12A):1606-1611. doi:10.1017/S1368980007361004.
- World Health Organization. Iodine supplementation in pregnant and lactating women. Updated August 9, 2023.. WHO: Iodine supplementation in pregnant and lactating women Accessed September 8, 2026
- Zhou SJ, Anderson AJ, Gibson RA, Makrides M. Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials. Am J Clin Nutr. 2013;98(5):1241-1254. doi:10.3945/ajcn.113.065854.
- Harding KB, Peña-Rosas JP, Webster AC, Yap CMY, Payne BA, Ota E, De-Regil LM. Iodine supplementation for women during the preconception, pregnancy and postpartum period. Cochrane Database Syst Rev. 2017;(3). doi:10.1002/14651858.CD011761.pub2.
Article information
Authors
- Prema RamachandranNutrition Foundation of IndiaCorresponding author · [email protected]
- Honey KumariNutrition Foundation of India
- Ransi Ann AbrahamAll India Institute of Medical Sciences New Delhi India
- Ramakrishnan LakshmyAll India Institute of Medical Sciences New Delhi India
- K KalaivaniNutrition Foundation of India
How to cite
Ramachandran, P., Kumari, H., et al., 2026. Urinary iodine excretion in women of reproductive age from urban low middle-income families in New Delhi, India. Medical Research Archives, [online] 14(10). https://doi.org/10.18103/mra.2026.0637
Record
- Journal
- Medical Research Archives
- Issue
- Vol 14 No 10 (2026)
- Section
- Research Articles
- Published
- 31 October 2026
- ISSN
- 2375-1924
- Downloads
- 60
Copyright and licence
Published by the European Society of Medicine under a Creative Commons Attribution 4.0 International licence (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original authors and source are credited.